Hopkins researchers find that blood test for ‘nicked’ protein predicts prostate cancer treatment response

Prostate cancer patients whose tumors contain a shortened protein called AR-V7, which can be detected in the blood, are less likely to respond to two widely used drugs for metastatic prostate cancer, according to results of a study led by researchers at the Johns Hopkins Kimmel Cancer Center. …read more

Source: Cancer